Marshall Wace North America L.P. - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 76 filers reported holding SILVERBACK THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$1,618,000
-40.6%
162,183
+175.9%
0.01%
-41.7%
Q4 2020$2,724,00058,7880.01%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Orbimed Advisors 8,740,887$87,234,0000.96%
Boxer Capital, LLC 1,675,377$16,720,0000.58%
EcoR1 Capital, LLC 1,184,710$11,823,0000.41%
Nantahala Capital Management 1,226,631$12,242,0000.39%
5AM Venture Management, LLC 169,748$1,694,0000.34%
COMMODORE CAPITAL LP 97,143$969,0000.26%
RA Capital Management 1,742,186$17,387,0000.24%
HighVista Strategies LLC 22,434$224,0000.15%
Rhenman & Partners Asset Management AB 150,000$1,497,0000.10%
Woodline Partners LP 425,261$4,244,0000.07%
View complete list of SILVERBACK THERAPEUTICS INC shareholders